PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2

被引:83
作者
Frese, S
Pirnia, F
Miescher, D
Krajewski, S
Borner, MM
Reed, JC
Schmid, RA
机构
[1] Univ Hosp Bern, Dept Clin Res, Div Gen Thorac Surg, CH-3010 Bern, Switzerland
[2] Univ Hosp Bern, Inst Med Oncol, CH-3010 Bern, Switzerland
[3] Burnham Inst, La Jolla, CA 92037 USA
关键词
lung cancer; resistance to apoptosis; tumor necrosis factor-related apoptosis-inducing ligand; mitogen-activated protein kinase; primary culture;
D O I
10.1038/sj.onc.1206842
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to the family of programmed cell death-inducing cytokines. Apo2L/TRAIL induces apoptosis in a wide variety of tumor cells. Tumor cells that are resistant to Apo2L/TRAIL-induced apoptosis can be sensitized by chemotherapeutic drugs and other agents via an unknown mechanism. Here we report that PG490 (triptolide), a diterpene triepoxide extracted from the Chinese herb Tripterygium wilfordii and used in traditional Chinese medicine, sensitizes lung cancer but not normal human bronchial epithelial cells to Apo2L/TRAIL-induced apoptosis. Sensitization was accompanied by caspase-3 and caspase-8 activation, whereas no cleavage of caspase-9 was observed. Determination of cell surface receptors by flow cytometry demonstrated no difference in Apo2L/TRAIL-R1 and -R2 expression, the two receptors with functional death domains, between resistant and sensitized cells. In cells treated with the combination of Apo2L/TRAIL and PG490, we observed activation of ERK2, a member of the mitogen-activated protein kinase family. Furthermore, sensitization could be blocked by the ERK inhibitor U0126 but not the p38 inhibitor SB203580, suggesting that activation of ERK2 is required for this effect. In addition, sensitization of lung cancer cells was also seen in ex vivo culture of lung cancer tissue from four patients who underwent surgery. Immunohistochemical staining showed a clear reduction in proliferation cell nuclear antigen (PCNA) in tissue treated with Apo2L/TRAIL and PG490. In conclusion, apoptosis induced by the combination of Apo2L/TRAIL and PG490 warrants further evaluation as a potential new strategy for the treatment of lung cancer.
引用
收藏
页码:5427 / 5435
页数:9
相关论文
共 40 条
[1]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[2]   Mammalian MAP kinase signalling cascades [J].
Chang, LF ;
Karin, M .
NATURE, 2001, 410 (6824) :37-40
[3]   Triptolide and chemotherapy cooperate in tumor cell apoptosis - A role for the p53 pathway [J].
Chang, WT ;
Kang, JJ ;
Lee, KY ;
Wei, K ;
Anderson, E ;
Gotmare, S ;
Ross, JA ;
Rosen, GD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (03) :2221-2227
[4]   Follicle-stimulating hormone activates extracellular signal-regulated kinase but not extracellular signal-regulated kinase kinase through a 100-kDa phosphotyrosine phosphatase [J].
Cottom, J ;
Salvador, LM ;
Maizels, ET ;
Reierstad, S ;
Park, Y ;
Carr, DW ;
Davare, MA ;
Hell, JW ;
Palmer, SS ;
Dent, P ;
Kawakatsu, H ;
Ogata, M ;
Hunzicker-Dunn, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :7167-7179
[5]   New insights into the control of MAP kinase pathways [J].
English, J ;
Pearson, G ;
Wilsbacher, J ;
Swantek, J ;
Karandikar, M ;
Xu, SC ;
Cobb, MH .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) :255-270
[6]   Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRIAL-induced apoptosis [J].
Evdokiou, A ;
Bouralexis, S ;
Atkins, GJ ;
Chai, F ;
Hay, S ;
Clayer, M ;
Findlay, DM .
INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (04) :491-504
[7]   Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats [J].
Faul, JL ;
Nishimura, T ;
Berry, GJ ;
Benson, GV ;
Pearl, RG ;
Kao, PN .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (06) :2252-2258
[8]   Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein [J].
Frese, S ;
Brunner, T ;
Gugger, M ;
Uduehi, A ;
Schmid, RA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (01) :168-174
[9]  
Gliniak B, 1999, CANCER RES, V59, P6153
[10]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36